Nasdaq

Masimo O3® Regional Oximetry Receives FDA Clearance for Somatic Applications and Measurement of Relative Changes in Cerebral Hemoglobin

O3 Regional Oximetry provides regional or tissue hemoglobin oxygen saturation with a trending specification of 3% ARMS* (cerebral and somatic, all ages) and absolute accuracy specifications of 4% ARMS ...
MobiHealthNews

Masimo scores extended FDA clearance for cerebral hemoglobin monitoring

Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin. It specifically ...
MedPage Today

Pulse Oximeters Choke Oxygen Delivery to Minorities in ICU

Minorities get less supplemental oxygen in the ICU, in large part due to poorer performance of pulse oximeters, a study showed. That averaged out to approximately 0.2 to 0.3 L/min less oxygen for ...
Business Wire

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

SAN FRANCISCO--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the ...
Medscape

Perioperative Optimization of Oxygen Delivery

Oxidative degradation of high-energy substrates is an essential feature of all living organisms. Aerobic organisms have developed complex chemical reactions, grouped under the term 'respiratory chain' ...
Nasdaq

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

Without ORi, there is no noninvasive way to monitor oxygenation under supplemental oxygen to manage hyperoxia, or higher than normal oxygenation of arterial blood. There is growing evidence that ...